ABT vs BIIB: Options Risk Comparison

ABBOTT LABORATORIES and BIOGEN INC. compared side by side — risk score, IV Rank, edge and earnings. Updated every 30 minutes.

Metric	ABT	BIIB
Risk Score	71	71
Risk Band	HIGH	HIGH
IV Rank	58.8	86.7
IV %	32.1%	48.2%
Edge Score	-12	+16
Price Δ	-3.8%	-0.7%
Next Earnings	2026-10-21	2026-10-28
Sector	Health Care	Health Care

Which has higher options risk?

Both carry an identical options risk score of 71 right now. For selling option premium, BIOGEN INC. (BIIB) has the better edge score (+16) — a stronger blend of high IV Rank and low risk.

Risk score (0–100) reflects active catalysts — earnings, legal, SEC filings and news. Edge score = IV Rank − risk score; higher is better for selling premium.

Run a full scan on each — free

Scan ABT → Scan BIIB →

Full risk pages

ABT risk, IV & earnings BIIB risk, IV & earnings

More Health Care comparisons

ABT vs ABBV ABT vs A ABT vs ALGN ABT vs AMGN ABT vs BAX ABT vs BDX ABT vs TECH ABT vs BSX

TickerRisk provides risk scoring for informational purposes only. Not financial advice. Options trading involves substantial risk of loss. Full disclaimer